miR-139-5p Cancer Research Results
miR-139-5p, miR-139-5p: Click to Expand ⟱
| Source: |
| Type: microRNA |
miR-139-5p is a microRNA that plays a significant role in post-transcriptional regulation of gene expression.
-miR-139-5p often targets multiple genes involved in cell cycle regulation, apoptosis, migration, and invasion.
-Majority of studies across various cancer types suggest that lower expressions of miR-139-5p are correlated with more aggressive tumor behaviors and poorer prognoses.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
Apoptosis↑, TumAuto↑, TumCCA↑, EMT↓, *ROS↓, *antiOx↑, ROS↑, P53↑, LC3II↑, Beclin-1/ATG6↑, p‑MAP2K1/MEK1↓, p‑ERK↓, BAX↑, cl‑Casp3↑, Bcl-2↓, p‑MAPK↓, DNArepair↓, HMGB1↓, XRCC1↓, ERCC3↑, CycB/CCNB1↓, CDC2↓, p‑CHK1↑, TumCCA↑, TumCP?, Wnt↓, β-catenin/ZEB1↓, miR-384↑, PTN↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, Ferroptosis↑, GPx4↓, eff↑, Ki-67↓, GSH↓, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, NF-kB↓, NOTCH↓, miR-139-5p↑, miR-34a↑, miR-422a↑, miR-107↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, E-cadherin↑, N-cadherin↓, Vim↓, HK1↓, FOXO1↓, compI↓, compIII↓, compV↓, ETC↓, BioAv↝,
tumCV↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, mTOR↓, PI3K↓, Akt↓, STAT3↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, Apoptosis↑, hTERT/TERT↓, AP-1↓, NF-kB↓, MAPK↓, HSP90↓, AR↓, IGF-1R↓, Akt↓, NOTCH↓, IL6↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, TumVol∅, TumW∅, miR-34a↑, miR-107↑, miR-139-5p↑, miR-422a↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, *toxicity↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
compV↓, 1, ERCC3↑, 1, miR-107↑, 2, miR-224↓, 2, miR-422a↑, 2, MMP16↓, 2, PTN↓, 1, XRCC1↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
compI↓, 1, Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 1, HK1↓, 1, PARK2↑, 1, ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC2↓, 1, compIII↓, 1, ETC↓, 1, MMP↓, 1, PINK1↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 3, Apoptosis↑, 2, BAX↑, 2, Bcl-2↓, 2, Bcl-xL↓, 1, cl‑Casp3↑, 2, Ferroptosis↑, 1, hTERT/TERT↓, 1, MAPK↓, 1, p‑MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
miR-21↓, 2, tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6↑, 1, LC3II↑, 2, p62↓, 1, TumAuto↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
p‑CHK1↑, 1, DNArepair↓, 1, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CycB/CCNB1↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
BMI1↓, 1, EMT↓, 1, p‑ERK↓, 1, FOXO1↓, 1, HDAC↓, 1, IGF-1R↓, 1, p‑MAP2K1/MEK1↓, 1, miR-34a↑, 2, mTOR↓, 2, mTOR↑, 1, NOTCH↓, 2, PI3K↓, 2, STAT3↓, 1, TumCG↓, 1, Wnt↓, 2,
Migration(tgid=13) ⓘ
AP-1↓, 1, E-cadherin↑, 2, Ki-67↓, 1, miR-139-5p↑, 3, miR-155↓, 2, miR-340↓, 2, miR-384↑, 1, MMP2↓, 2, MMP3↓, 2, MMP9↓, 2, N-cadherin↓, 2, Snail↓, 1, TumCI?, 1, TumCI↓, 2, TumCMig↓, 2, TumCP?, 1, TumCP↓, 2, TumMeta↓, 2, Vim↓, 2, β-catenin/ZEB1↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
HMGB1↓, 1, IL6↓, 1, NF-kB↓, 2,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
AR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 1, eff↓, 1, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
AR↓, 1, hTERT/TERT↓, 1, IL6↓, 1, Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1, TumVol∅, 1, TumW∅, 1,
Total Targets: 95
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, ROS↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 3
Scientific Paper Hit Count for: miR-139-5p, miR-139-5p
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1238 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page